BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23948182)

  • 21. PA-MSHA induces apoptosis and suppresses metastasis by tumor associated macrophages in bladder cancer cells.
    Liu J; Duan X
    Cancer Cell Int; 2017; 17():76. PubMed ID: 28824336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of the epidermal growth factor receptor in bladder cancer cells treated with the DNA-damaging drug etoposide markedly increases apoptosis.
    Munk M; Memon AA; Nexo E; Sorensen BS
    BJU Int; 2007 Jan; 99(1):196-201. PubMed ID: 17092291
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancer.
    Black PC; Brown GA; Dinney CP; Kassouf W; Inamoto T; Arora A; Gallagher D; Munsell MF; Bar-Eli M; McConkey DJ; Adam L
    J Urol; 2011 Feb; 185(2):693-700. PubMed ID: 21168861
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paeonol inhibits proliferation and induces cell apoptosis of human T24 and 5637 bladder cancer cells in vitro and in vivo.
    Zhang JJ; Cai LJ; Pang K; Dong Y; Zhang ZG; Li BB; Li R; Han CH
    Clin Transl Oncol; 2021 Mar; 23(3):601-611. PubMed ID: 32691366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PA-MSHA Regulates PD-L1 Expression in Hepatoma Cells.
    Wei H; Mao Y; Zhang H; Wu F; Zhang Y
    Immunol Invest; 2023 Apr; 52(3):343-363. PubMed ID: 36762677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor effects of recombinant human interleukin-6 on mouse bladder carcinoma through Fas-mediated apoptosis.
    Li CG; Li ML; Shu XH; Liu YJ; Wu WS
    Cancer Chemother Pharmacol; 2010 Oct; 66(5):981-6. PubMed ID: 20499068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Caveolin-1 acts as a tumor suppressor by down-regulating epidermal growth factor receptor-mitogen-activated protein kinase signaling pathway in pancreatic carcinoma cell lines.
    Han F; Gu D; Chen Q; Zhu H
    Pancreas; 2009 Oct; 38(7):766-74. PubMed ID: 19893453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib (ZD1839, Iressa) in non-small cell lung cancer cell lines correlates with gene copy number and EGFR mutations but not EGFR protein levels.
    Helfrich BA; Raben D; Varella-Garcia M; Gustafson D; Chan DC; Bemis L; Coldren C; Barón A; Zeng C; Franklin WA; Hirsch FR; Gazdar A; Minna J; Bunn PA
    Clin Cancer Res; 2006 Dec; 12(23):7117-25. PubMed ID: 17145836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor effects of exogenous ganglioside GM3 on bladder cancer in an orthotopic cancer model.
    Wang H; Isaji T; Satoh M; Li D; Arai Y; Gu J
    Urology; 2013 Jan; 81(1):210.e11-5. PubMed ID: 23102779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MSHA strain of Pseudomonas aeruginosa (PA-MSHA) inhibits gastric carcinoma progression by inducing M1 macrophage polarization.
    Wang C; Hu Z; Zhu Z; Zhang X; Wei Z; Zhang Y; Hu D; Cai Q
    Tumour Biol; 2016 May; 37(5):6913-21. PubMed ID: 26662800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor alpha expression drives constitutive epidermal growth factor receptor pathway activation and sensitivity to gefitinib (Iressa) in human pancreatic cancer cell lines.
    Pino MS; Shrader M; Baker CH; Cognetti F; Xiong HQ; Abbruzzese JL; McConkey DJ
    Cancer Res; 2006 Apr; 66(7):3802-12. PubMed ID: 16585207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PA-MSHA inhibits proliferation and induces apoptosis in human non-small cell lung cancer cell lines with different genotypes.
    Zhao X; Wu X; Yu W; Cai X; Liu Q; Fu X; Liu Z; Hu D; Pan S; Huang Q
    Mol Med Rep; 2016 Dec; 14(6):5369-5376. PubMed ID: 27779712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways.
    Pan Q; Yang GL; Yang JH; Lin SL; Liu N; Liu SS; Liu MY; Zhang LH; Huang YR; Shen RL; Liu Q; Gao JX; Bo JJ
    J Exp Clin Cancer Res; 2015 Aug; 34(1):77. PubMed ID: 26245871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic antitumor activity of epidermal growth factor receptor tyrosine kinase inhibitor gefitinib and IFN-alpha in head and neck cancer cells in vitro and in vivo.
    Bruzzese F; Di Gennaro E; Avallone A; Pepe S; Arra C; Caraglia M; Tagliaferri P; Budillon A
    Clin Cancer Res; 2006 Jan; 12(2):617-25. PubMed ID: 16428508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in epidermal growth factor receptor expression in human bladder cancer cell lines following interferon-alpha treatment.
    Qu XJ; Yang JL; Russell PJ; Goldstein D
    J Urol; 2004 Aug; 172(2):733-8. PubMed ID: 15247772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
    Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
    Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR].
    Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bladder cancer cell-derived exosomes inhibit tumor cell apoptosis and induce cell proliferation in vitro.
    Yang L; Wu XH; Wang D; Luo CL; Chen LX
    Mol Med Rep; 2013 Oct; 8(4):1272-8. PubMed ID: 23969721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cells.
    Park JJ; Yi JY; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
    Biochem Pharmacol; 2012 Apr; 83(7):849-57. PubMed ID: 22266356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidermal growth factor receptor signaling pathway involved in progestin-resistance of human endometrial carcinoma: In a mouse model.
    Xu Y; Tong J; Ai Z; Wang J; Teng Y
    J Obstet Gynaecol Res; 2012 Dec; 38(12):1358-66. PubMed ID: 22612393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.